F rom 1999 to 2014, the death rate from drug overdose in the United States has tripled, from 4.71 deaths to 13.56 deaths per 100 000 population, 1 creating a public health crisis. This marked increase is driven primarily by prescription opioid overdose and, in recent years, heroin and fentanyl. 1 Since 1999, the rate of overdose deaths involving opioids (including prescription opioids and heroin) has nearly quadrupled. With drug overdose mortality continuing to rise, effective interventions, such as enhanced state prescription drug monitoring programs and bystander-first responder naloxone training, are urgently needed. [2] [3] [4] [5] To inform surveillance programs and prevention initiatives, it is necessary to better understand the dynamics of the opioid epidemic over time and across different population groups. Existing literature on trends in drug overdose mortality indicates that there may be age, period, and cohort effects. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Age effect refers to variance over time that is specific to a certain age group. For example, the highest mortality from drug overdose for both sexes in the United States occurs among people aged 45 to 54 years. 6 Historically, men in their late 20s to early 30s have had a higher risk of fatal overdoses than have other age groups. 9, 10 Period effect refers to variance over time that is common across all age groups. For example, as heroin has become less expensive and more accessible than prescription opioids, that increase in accessibility may influence all age groups. Indeed, from 2010 to 2012, the heroin death rate increased for all age groups, whereas the opioid analgesic mortality rate declined for individuals younger than 45 years. 11 Public policies to restrict opioid prescribing have shown promising results in reducing opioid prescriptions in the United States, 21 although overdoses have continued to increase. 22 A growing body of evidence indicates that some individuals who use prescription opioids nonmedically have been shifting to heroin, [12] [13] [14] [15] [16] [17] [18] although the incidence of heroin use among those who are naïve to prescription opioids has also increased.
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Cohort effect refers to variance over time that is specific to a certain birth cohort. For example, people aged 45 to 64 years accounted for nearly half of all overdose deaths from prescription opioids between 1999 and 2014, an effect disproportionate to other deaths for that age group and for overdose deaths overall across time. In the study of morbidity and mortality in midlife (ages 45-54 years) among non-Hispanic White Americans, the death rate from poisoning has continued increasing since 1998. 20 In 2010, the death rate from poisoning exceeded the death rate from lung cancer and became a leading cause of death in this age group. 20 Drug overdose mortality has been a driver of the overall increase in midlife mortality for US non-Hispanic Whites after 1998. 20 Regarding heroin specifically, people aged 25 to 34 years have the highest burden of overdose, with a higher rate than any other age group from 2007 to 2012. 11 However, cohort patterns in opioid overdose mortality have not been adequately explored. Evidence regarding specific birth cohorts at high risk for overdose mortality can help identify the target population groups for intervention and help to understand the dynamics of the overdose epidemic more broadly. Age-period-cohort analysis is a classic approach to understanding health trends over time. If population-level variation in drug overdose mortality differs by both age and time period, as it does in the United States, then a birth cohort effect explaining trends over time may arise. Cohort effects are defined as variations in risk patterns ascribed to individuals born in the same time period who share exposure to certain risk factors or common life experiences. Cohort analysis is a technique for quantifying the excess risk for a given disease or injury experienced by particular birth cohorts.
Thus, to improve understanding of the population-level influences on death rates from prescription opioid and heroin overdose over time, we performed an age-periodcohort analysis to examine whether prescription opioid and heroin affected different birth cohorts of the US population. The present study assesses cohort effects in prescription opioid and heroin overdose mortality in the United States over the past 15 years using national vital statistics data. It also examines differences in cohort effects between sexes.
METHODS
Estimates are based on the multiple-causeof-death mortality files released by the National Vital Statistics System. Children aged 16 years and younger and people aged 66 years and older were excluded because of an insufficient number of drug overdose deaths for robust estimates. Deaths were classified using the International Classification of Diseases, 10th Revision (ICD-10). 23 Included in this analysis were unintentional drug-poisoning deaths (defined as having an ICD-10 underlying cause-of-death code of X40-X44) and drug-poisoning deaths with undetermined intent (defined as having an ICD-10 underlying cause-of-death code of Y10-Y14). Drug-poisoning deaths involving prescription opioid analgesics include those with an ICD-10 code of T40.2, T40.3, or T40.4. Although in recent years it has been manufactured mostly illicitly, fentanyl is coded as a prescription opioid (T40.4) in the National Vital Statistics System. Drug-poisoning deaths involving heroin include those with an ICD-10 code of T40.1. The analysis begins with 1999 because of changes in the classification of individual drugs and drug classes that cannot be easily reconciled with past ICD revisions. The analysis ends with 2014, the most recent year for which publicly released data were available at the time of the study. Multiple-causeof-death mortality data files provide data for all deaths occurring in the United States. Death certificates are generally completed by attending physicians, medical examiners, and coroners. 24 Previous studies have shown that about 25% of US overdose deaths had no drug information on the death certificate, so it is likely that national statistics underestimate the number of opioid-related deaths.
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Conceptualize Cohort Effect
The data are separated into m age groups within n periods in a contingency table. The drug overdose mortality rates, denoted as Y ij in the model, are presented for each i = 1, . . ., m and j = 1, . . ., n in an m · n contingency table (Tables A and B , available as a supplement to the online version of this article at http://www.ajph.org). The age-periodcohort analysis requires the same year interval for age and period. In this study, age and period are grouped with 2-year intervals instead of conventional 5-year intervals because the drug overdose mortality data cover a 16-year period only. There are not enough overdose deaths for reliable estimates for children aged 16 years and younger and people aged 66 years and older. As a result, the contingency table has 25 age groups In this study, the cohort effects are conceptualized as partial interactions between period and age because linear cohort effects are dependent on linear age and period (cohort = period -age). Thus, nonlinear covariation in age and period effects that are correlated with birth cohorts is uniquely identifiable and conceptually meaningful. 25 This definition of cohort effect is consistent with the objective to better understand the effects of environmental causes on the patterns of disease among different populations in epidemiological research. 26 
Statistical Analysis
In the statistical analysis, the logarithm of the mortality rate is expressed as a linear component and a nonlinear component of age and period effects. The cohort effects are quantified in the nonlinear component 25 :
where the effect of the ith age is given by a i and the effect of the jth period by b j and where m is a constant term and e ij is an error term representing residuals unexplained by the log-additive effects of age and period. Through graphical representation, median polish, and regression analysis, the cohort effect is isolated from the error term in Equation 1 and quantified in the regression model. First, the possible existence of cohort effects is examined through graphs of age-specific mortality rates across periods or cohorts, period-specific mortality rates across age or cohorts, and cohort-specific mortality rates across age or periods. For example, in considering age-specific mortality rates across periods (year of death), if the mortality rates do not change over time, we cannot conclude that there are meaningful period or cohort effects. If age-specific mortality rates change over time in a parallel way, we can conclude that the variation is best described as a period effect. If age-specific mortality rates change over time during a specific time period, and in a significantly different way from other age groups, we can conclude that the variation is best described as including cohort effects.
Second, median polish removes the additive effect (linear component) of age and period so that the presence and size of cohort effects (nonlinear component) can be evaluated. The mortality rates are log transformed before the median polish process. After iteratively subtracting the median from the rows (periods) and columns (ages), the row and column median values are approximately zero. As a result, the residuals in the contingency table can be considered as the cohort effect plus random error. In the plot of residuals against cohort categories, the residuals evenly distribute around zero if no cohort effects exist; a significant deviation from zero indicates the presence of cohort effects.
Third, the residuals obtained via the median polish are regressed on intercept, a vector of cohort effects, and a vector of error terms in Equation 2, using a linear regression to obtain the ratio of the cohort effect for each cohort relative to the reference cohort effect. We also need to evaluate the distribution of the regression residual of each cohort to determine whether the mortality data meet the assumption of the regression model.
where e k denotes the random error unexplained by the linear component of ith age and jth period effects in Equation 1 ; m k , intercepts in kth cohort; g k , cohort effects in kth cohort; and e ijk , error term in the ith age group, jth period, and kth cohort. Parameter estimates in the regression model were interpreted as the log of the relative risk of cohort effect. In the study, the birth cohort of 1977 to 1978 was adopted as the reference group because the mean residual of this birth cohort is approximately zero and the prescription opioid and heroin overdose mortality rates for this birth cohort are almost identical with and without cohort effects across age groups. Given the sex differences in the trends over time in opioid overdoses, all analyses were stratified by sex, and multiplicative interactions between cohort effects and sex were tested with the standard F test.
RESULTS
The age-specific overdose death rates across time periods were graphed in Figure A (available as a supplement to the online version of this article at http://www.ajph. org). For simplicity, ages were grouped in 5-year intervals. Both prescription opioid and heroin overdose death rates exhibited curvilinear shapes. However, compared with the previous years, prescription opioid overdose death rates increased more slowly after 2007 in most age groups except the 16-to 30-year age group ( Figure A) . Heroin overdose death rates in all age groups increased more quickly after 2007 compared with the previous years ( Figure A) .
Before 2010, the age-specific death rates increased steadily in a parallel fashion for both prescription opioid and heroin overdose death rates ( Figure A) . Since 2010, the prescription opioid overdose death rate for those in their late 40s to 60s increased faster than did those for other age groups. By comparison, heroin overdose death rates for those in their 20s and 30s increased faster than those for other age groups since 2010. These nonparallel increases indicate that period and age effects alone may not be sufficient to explain the changes in the graphically presented data.
Additionally, we graphed cohort-specific overdose death rates across age groups ( Figure  1 ). In prescription opioid overdose death rates, individuals born between 1947 and 1964 had parallel trends in their early ages compared with other birth cohorts. However, prescription opioid overdose death rates started to decline among people born after 1964 in their older ages, whereas the increase in death rates continued in other birth cohorts. Heroin overdose death rates increased faster in the younger ages among people born after 1971 than among older birth cohorts. Such nonparallel trends in both prescription opioid and heroin overdose death rates indicate that cohort effects might exist.
Median Polish
The death rates were log-transformed before the median polish process, which removed the log-additive effect of age and period so that we could assess the presence and size of cohort effects by plotting the residuals against cohort categories in Figure B (available as a supplement to the online version of this article at http://www.ajph.org). For prescription opioid overdose deaths, there was evidence of a cohort effect for those born between 1947 and 1964. A deviation of the residuals from zero for those born between 1951 and 1962 and for those born between 1979 and 1992 indicates that there was a positive cohort effect on heroin overdose death rates. We then compared the differences between cohort-specific death rates by age with and without cohort influence. The results from the median polish analysis were consistent with the patterns revealed in the graphic presentations.
Regression
Residuals obtained through the median polish analysis were regressed on intercept, a vector of cohort effects, and a vector of error terms in Equation 2 using a linear regression. The exponentiated regression coefficients along with 95% confidence intervals (CIs) from this model are interpreted here as the ratios of the cohort effects relative to the 1977 to 1978 cohort ( Table 1 ). The rate ratios (RRs) of cohort effects were graphed across the birth cohorts ( Figure C A high rate of illicit drug use among baby boomers is well documented. 27 As the baby boom generation ages, older patients may be prescribed more opioids than may other age groups; thus, abuse could become an even greater problem. 27 The characteristics of baby boom cohorts, including unique vulnerabilities to drug abuse caused by increased use of illicit drugs in adolescence, complicate treatment caused by undiagnosed psychiatric and medical comorbidities and unwillingness to actively seek treatment 27 and might explain their higher death rates from prescription opioid overdose and heroin overdose. 28 Several studies have suggested that men are at higher risk for opioid overdose death than are women. 6, 7, 28 We conducted separate analyses for prescription opioid overdose mortality and heroin overdose mortality stratified by sex. The results indicate that male baby boomers experienced stronger cohort effects in prescription opioid overdose mortality than did female baby boomers. A previous age-period-cohort analysis indicated that both Black and White baby boomers had a higher risk of unintentional overdose mortality than did the cohorts that came before and after them. 28 We also found a significant cohort effect ascribed to those born between 1979 and 1992 in heroin overdose mortality. Although the adverse health consequences of heroin use are widely known, the availability of the substance and the desire for new experiences may drive young adults to initiate heroin use. 29 The cohort pattern in heroin overdose deaths is cause for concern because most of the policy interventions designed to control the opioid epidemic, such as state prescription drug monitoring programs, target prescription analgesics and would have little impact on the heightened heroin overdose mortality among young adults.
Our findings are subject to 3 notable limitations. First, vital statistics underestimate the rates of prescription and illicit drug overdose deaths because the type of drug is not specified on many death certificates. 30 Second, deaths from heroin overdose might be underreported as a result of misclassification because toxicological testing is used to detect the metabolites of heroin, such as morphine, rather than heroin itself. 31 To the extent that the underestimation is systematic, it does not pose a serious threat to the validity of our findings because our study focuses on trends over time and not the true level of drug overdose mortality in any specific year. Finally, the cohort effect in heroin overdose mortality reported in this study is likely incomplete because individuals born between 1993 and 2000 (part of the millennial generation) have not been fully exposed to the opioid epidemic. Despite these limitations, this study contributes new insights on the epidemiological patterns in prescription opioid overdose and heroin overdose mortality and helps advance understanding of the role of cohort effects in the evolution of the opioid epidemic in the United States.
Results of this study indicate that baby boomers have experienced significantly higher mortality from prescription opioid and heroin overdose than has the reference cohort (those born in [1977] [1978] . In addition, individuals born between 1979 and 1992 are at significantly increased risk for death from heroin overdose. These cohort patterns are present in both sexes. These findings point to the need for prevention programs and policies tailored to address the excess overdose mortality risks in specific demographic groups.
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